Epithalon Peptide Activates Telomerase and Lengthens Telomeres in Human Cells
The synthetic tetrapeptide Epithalon (Ala-Glu-Asp-Gly) activated telomerase and lengthened telomeres in telomerase-negative human fibroblasts, demonstrating anti-aging potential at the chromosomal level.
Quick Facts
What This Study Found
Epithalon peptide (Ala-Glu-Asp-Gly) induced telomerase catalytic subunit (hTERT) expression, telomerase enzymatic activity, and telomere elongation in telomerase-negative human fetal fibroblasts.
Key Numbers
How They Did This
In-vitro study adding Epithalon to telomerase-negative human fetal fibroblast cultures. Telomerase catalytic subunit expression, enzymatic activity, and telomere length measured.
Why This Research Matters
Telomere shortening is one of the most fundamental mechanisms of aging. A simple peptide that reactivates telomerase could potentially slow or reverse cellular aging.
The Bigger Picture
Anti-aging research targets telomere biology as one of aging's root causes. A peptide that safely activates telomerase could represent a practical anti-aging intervention — if safety concerns (cancer risk from unlimited cell division) can be managed.
What This Study Doesn't Tell Us
In-vitro fibroblast study. Telomerase activation could promote cancer if uncontrolled. In-vivo effects and safety not assessed. Very short abstract limits detail.
Questions This Raises
- ?Does Epithalon increase cancer risk through telomerase activation?
- ?Can systemic Epithalon administration slow aging in animals?
- ?What is the optimal dose and duration for anti-aging benefits?
Trust & Context
- Key Stat:
- Telomeres lengthened Epithalon reactivated telomerase in cells that had none, actually lengthening telomeres — reversing a fundamental aging mechanism at the chromosomal level
- Evidence Grade:
- Preliminary in-vitro evidence with clear molecular endpoints (hTERT expression, telomerase activity, telomere length) in a defined cell system.
- Study Age:
- Published in 2003. Epithalon has been studied further in animal longevity models with intriguing results, though clinical evidence remains limited.
- Original Title:
- Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells.
- Published In:
- Bulletin of experimental biology and medicine, 135(6), 590-2 (2003)
- Authors:
- Khavinson, V Kh(3), Bondarev, I E(2), Butyugov, A A(2)
- Database ID:
- RPEP-00833
Evidence Hierarchy
Frequently Asked Questions
Can a peptide reverse aging?
At the cellular level, this study suggests yes — Epithalon activated telomerase and lengthened telomeres in human cells, reversing one of aging's fundamental mechanisms. Whether this translates to anti-aging in whole organisms is still being studied.
Is this safe?
The major concern is cancer. Telomerase is normally suppressed in adult cells partly as a cancer defense (cells can't divide forever). Reactivating it could theoretically promote cancer. This safety question must be resolved before clinical use.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00833APA
Khavinson, V Kh; Bondarev, I E; Butyugov, A A. (2003). Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells.. Bulletin of experimental biology and medicine, 135(6), 590-2.
MLA
Khavinson, V Kh, et al. "Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells.." Bulletin of experimental biology and medicine, 2003.
RethinkPeptides
RethinkPeptides Research Database. "Epithalon peptide induces telomerase activity and telomere e..." RPEP-00833. Retrieved from https://rethinkpeptides.com/research/khavinson-2003-epithalon-peptide-induces-telomerase
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.